RMP-7: Began Phase I/II trial

Alkermes Inc. (ALKS), Cambridge, Mass. Product: RMP-7 receptor-mediated permeabilizer-7, plus the chemotherapeutic carboplatin Indication: Advanced malignant glioma Status: Began Phase I/II trial in t...